期刊文献+

CXXC5 suppresses hepatocellular carcinoma by promoting TGF-β-induced cell cycle arrest and apoptosis 被引量:3

CXXC5 suppresses hepatocellular carcinoma by promoting TGF-β-induced cell cycle arrest and apoptosis
原文传递
导出
摘要 Evading TGF-β-mediated growth inhibition is often associated with tumorigenesis in liver, including hepatocellular carcinoma (HCC). To better understand the functions and the underlying molecular mechanisms of TGF-β in HCC initiation and progression, we carried out transcriptome sequencing (RNA-Seq) to identify the target genes of TGF-β. CXXCS, a member of the CXXC-type zinc finger domain-containing protein family, was identified as a novel TGF-β target gene in Hep3B HCC cells. Knockdown of CXXC5 attenuated the expression of a substantial portion of TGF-p target genes and ameliorated TGF-13-induced growth inhibition or apoptosis of Hep3B cells, suggesting that CXXC5 is required for TGF-p-mediated inhibition of HCC progression. Analysis of the TCGA database indicated that CXXC5 expression is reduced in the majority of HCC tissue samples in comparison to that in normal tissues. Furthermore, CXXC5 associates with the histone deacetylase HDAC1 and competes its interaction with Smad2/3, thereby abolishing the inhibitory effect of HDAC1 on TGF-β signaling. These observations together suggest that CXXC5 may act as a tumor suppressor by promoting TGF-β signaling via a positive feedback loop, and reveal a strategy for HCC to bypass TGF-β-mediated cytostasis by disrupting the positive feedback regulation. Our findings shed new light on TGF-β signaling regulation and demon- strate the function of CXXC5 in HCC development.
出处 《Journal of Molecular Cell Biology》 SCIE CAS CSCD 2018年第1期48-59,共12页 分子细胞生物学报(英文版)
关键词 hepatocellular carcinoma (HCC) TGF-Β CXXC5 HDAC signaling regulation apoptosis 压制 周期 房间 目标基因 生长抑制 HCC
  • 相关文献

参考文献1

二级参考文献27

  • 1Lin L,Amin R,Gallicano GI,Glasgow E,Jogunoori W,Jessup JM,Zasloff M,Marshall JL,Shetty K,Johnson L,Mishra L,He AR. The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling. Oncogene 2009; 28: 961-972.
  • 2Coulouarn C,Factor VM,Thorgeirsson SS. Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer. Hepatology 2008; 47: 2059-2067.
  • 3Massagué J,Blain SW,Lo RS. TGFbeta signaling in growth control,cancer,and heritable disorders. Cell 2000; 103: 295-309.
  • 4Caja L,Sancho P,Bertran E,Iglesias-Serret D,Gil J,Fabregat I. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4. Cancer Res 2009; 69: 7595-7602.
  • 5Sohn BH,Park IY,Lee JJ,Yang SJ,Jang YJ,Park KC,Kim DJ, Lee DC,Sohn HA,Kim TW,Yoo HS,Choi JY,Bae YS,Yeom YI. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter. Gastroenterology 2010; 138: 1898-1908.
  • 6Dooley S,Weng H,Mertens PR. Hypotheses on the role of transforming growth factor-beta in the onset and progression of hepatocellular carcinoma. Dig Dis 2009; 27: 93-101.
  • 7Wakef ield LM,Roberts AB. TGF-beta signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev 2002; 12: 22-29.
  • 8Kitisin K,Ganesan N,Tang Y,Jogunoori W,Volpe EA,Kim SS,Katuri V,Kallakury B,Pishvaian M,Albanese C,Mendelson J,Zasloff M,Rashid A,Fishbein T,Evans SR,Sidawy A,Reddy EP,Mishra B,Johnson LB,Shetty K,Mishra L. Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation. Oncogene 2007; 26: 7103-7110.
  • 9Senturk S,Mumcuoglu M,Gursoy-Yuzugullu O,Cingoz B,Akcali KC,Ozturk M. Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth. Hepatology 2010; 52: 966-974.
  • 10Hjelmeland AB,Hjelmeland MD,Shi Q,Hart JL,Bigner DD, Wang XF,Kontos CD,Rich JN. Loss of phosphatase and tensin homologue increases transforming growth factor betamediated invasion with enhanced SMAD3 transcriptional activity. Cancer Res 2005; 65: 11276-11281.

共引文献12

同被引文献9

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部